Reevaluation of baseline staging tests in breast cancer; what should be the standart?

Decision about staging of the patients with pT2-3NO-1, (N <3) diseases should be individualized according to patients' and doctors' preferences and economic resources.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:There has been an ongoing debate on staging in breast cancer.

📊

Key Findings & Data:In this study, we evaluated the metastasis détection rate with baseline staging of breast cancer after operation.

💡

Conclusion & Impact:Decision about staging of the patients with pT2-3NO-1, (N <3) diseases should be individualized according to patients' and doctors' preferences and economic resources.

🔬Design:Research Article

📍Scope:2000 Verileri

⚙️Variables:Risk değerlendirmesi · Meme neoplazmları · Tanısal görüntüleme

Abstract

There has been an ongoing debate on staging in breast cancer. In this study, we evaluated the metastasis détection rate with baseline staging of breast cancer after operation. One hundred consecutive breast cancer patients were evaluated with liver ultrasonography, chest X-ray and bone scans. All patients were followed at least for 6 months. More than one third of our patients belong to the high risk group (axillary involvement >3). In 3 patients (3%) metastasis were detected. Two of them (5,8%) were in the group with pT4, N2 or N1 (N >3), one of them (2,7%) was in the group with pT2-3NO-1 (N s3). There was no metastasis in patients with pT1 NO-1 (N s3). To detect one case of occult metastasis 2000 euro were spent. As a result, routine staging does not have a major impact on individual adjuvant treatment planning. We recommend routine staging only for patients with pT4 or N1, (N >3) or N2 disease, and we do not recommend staging for patients with pT1NO-1, (N s3) positive nodes. Decision about staging of the patients with pT2-3NO-1, (N <3) diseases should be individualized according to patients' and doctors' preferences and economic resources.

Keywords

Risk değerlendirmesi Meme neoplazmları Tanısal görüntüleme Neoplazm evrelendirilmesi Ultrasonografi Risk Assessment Breast Neoplasms Diagnostic Imaging Neoplasm Staging Ultrasonography

🔖

Cite This Article

SAMUR, M., BOZCUK, H. Ş., KARAVELİ, Ş., PEŞTERELİ, E., ÖZDOĞAN, M., YILDIZ, M., ARTAÇ, M., SAVAŞ, B. (2003). Reevaluation of baseline staging tests in breast cancer; what should be the standart?. Turkish Journal of Cancer, Cilt: 33 - Sayı: 3, 150–153. https://ajindex.com/articles/368355

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (15)

Myers ME, Johnston M, Pritchard K, Levine M, Oliver T and Breast Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative. Baseline staging tests in primary breast cancer: a practice guideline. CMAJ 2001;164:1439-44
Cooke AL. Baseline staging tests for breast cancer. CMAJ 2002;166:419
Ravaioli A, Tassinari D, Pasini G, et al. Staging of breast cancer: What standards should be used in research and clinical practice? Ann Oncol 1998;9:1173-7
Tassinari D, Sartori S, Ravaioli A. Staging of breast cancer. Is the evidence so evident? Ann Oncol 2001;12:1653
Curigliano G, Ferretti G, Colleoni M, et al. Bone scan has no role in the staging of 765 consecutive operable T(1-2)N(0- 1) breast cancer patients without skeletal symptoms. Ann Oncol 2001;12:724-5
Khansur T, Haick A, Patel B, et al. Evaluation of bone scan as a screening work-up in primary and local-regional recurrence of breast cancer. Am J Clin Oncol 1987;10:167-70
Coleman RE, Rubens RD, Fogelman I. Reappraisal of the baseline bone scans in breast cancer. J Nucl Med 1988;29:1045-9
Kennedy H, Kennedy N, Barclay M, et al. Cost effectivity of bone scans in breast cancer. Clin Oncol 1991;3:73-7
Yeh KA, Fortunato L, Ridge JA, et al. Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money. Ann Surg Oncol 1995;2:319-24
Cox MR, Gilliland R, Odling-Smee-GW, et al. An evaluation of radionuclide scanning and liver ultrasonography for staging breast cancer. Austr NZ J Surg 1992;32:550-5
Glynne-Jones R, Young T, Ahmed A, et al. How far investigations for occult metastases in breast cancer aid the clinician. Clin Oncol (R Coll Radiol) 1991;3:65-72
Ciatto Ciatto S, Pacini P, Azzini V, et al. Preoperative staging of primary breast cancer. A multicentric study. Cancer 1988;61:1038-40
Chen EA, Carlson GA, Coughlin BF, et al. Routine chest roentgenography is unnecessary in the work up of stage I and II breast cancer. J Clin Oncol 2000;18:3503-6
Ravaioli A, Pasini G, Polselli A, et al. Staging of breast cancer: new recommended standard procedure. Breast Cancer Res Treat 2002;72:53-60
Bozcuk HS, Uslu G, Peştereli E, et al. Predictors of distant metastasis at presentation in breast cancer: A study also evaluating associations among common biologic indicators. Breast Cancer Res Treat 2001;68:239-48.